Key Construction Projects in Guangdong Province 2023

Apr.19.2023
Key Construction Projects in Guangdong Province 2023
Guangdong Province 2023 construction plan includes four electronic cigarette-related projects, with a total investment of 585 million yuan.

Recently, the Guangdong Province 2023 Key Construction Project Plan was approved at the first session of the 14th Guangdong Provincial People's Congress. According to the notification issued by the Guangdong Provincial Development and Reform Commission, a total of 1,530 key projects will be arranged for 2023 in the province, with a total investment of CNY 8.5 trillion and an annual planned investment of CNY 1 trillion. Additionally, 1,090 provincial key preliminary construction projects will be arranged for preliminary work, with an estimated total investment of CNY 4.6 trillion.


Out of 1090 key construction projects, there are four electronic cigarette-related company factories included: Macrell, Smoore, Botton, and Han Qingda. These four projects are located in Jiangmen, Huizhou, and Foshan, with a total investment of 5.85 billion yuan.


The following project information is disclosed:


McAvell establishes electronic technology industrial park in Jiangmen.


The McGregor Electronic Technology Industrial Park Project is located in the Jianghai district of Jiangmen city, Guangdong province.


The total project investment amounts to 3 billion yuan. As of the end of 2022, a cumulative investment of 1 billion yuan has been completed, with plans to invest an additional 200 million yuan in 2023.


The project involves the construction of new factory buildings for the production of high-end electronic atomizer core components and other electronic device manufacturing.


The construction period will start in 2019 and end in 2024.


McWherter Project Information | Image source: Guangdong Provincial Development and Reform Commission


Simula establishes new materials technology industrial park in Jiangmen.


The Simore New Materials Technology Industrial Park project is located in Jiangmen City, Guangdong Province, China.


The total project investment is 1 billion yuan. As of the end of 2022, 36 million yuan has been invested cumulatively, and there are plans to invest 150 million yuan in 2023.


The project construction includes the establishment of a research, development, production, and sales headquarters for electronic heating elements and atomized materials.


The construction period is from 2022 to 2025.


Smor Project Information | Image Source: Guangdong Development and Reform Commission


China's "Boton" has built its Zhongkai "Boton" electronic atomizer headquarters and intelligent manufacturing base in Huizhou.


The headquarters and intelligent manufacturing base project of Zhongkai Podton Electronic Atomizer in China is located in Huizhou City, Guangdong Province.


The total investment of the project is 1.2 billion yuan, with plans to invest an additional 500 million yuan in 2023.


The construction project includes the production and operation of electronic atomizers, medical equipment and other related products.


The construction is scheduled to take place from 2023 to 2025.


Information about China's Bode project | Image source: Guangdong Development and Reform Commission.


Hanqingda establishes High Ming Intelligent Manufacturing Base in Foshan.


The HQD project for the construction of a high-tech manufacturing base is located in the Hecheng Street area of Foshan City, Guangdong Province.


The total investment in the project is 650 million yuan, with plans to invest an additional 100 million yuan by 2023.


The construction project includes facilities such as an e-cigarette production plant and planned supporting infrastructure like the first and last transit stops.


The construction period for the project is from 2023 to 2025.


Project Information of Hanqingda | Image Source: Guangdong Provincial Development and Reform Commission


For more related news, please follow 2FIRSTS.


Further Reading:


Semiconductor manufacturer SMIC reports a 97.7% decrease in revenue in the Chinese mainland market for the first quarter, while overseas markets experience a growth of 58.2%.


Macquarie plans to buy 3.5 billion yuan of structured deposits from Bank of China.


China's Boton is reportedly planning to purchase industrial land in Huizhou to construct a new headquarters and a manufacturing base for electronic atomizers.


References:


Notice from Guangdong Provincial Development and Reform Commission regarding the issuance of the 2023 major construction project plan for Guangdong Province.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
BAT Rothmans says it previously considered exiting South Korea's vaping market because of competitive pressure from unregulated products, but is now reassessing conditions following changes to the country's nicotine regulatory framework. Vuse and other BAT vaping products remain available through existing distribution channels. The statement followed a South Korean media report that interpreted BAT's broader withdrawal from selected Vapour markets as a full exit from South Korea. Meanwhile, Philip Morris International launched VEEV inPRIME in the country in June and began expanding distribution to around 14,000 convenience stores and other retail channels in July. The contrasting moves highlight differing investment strategies as South Korea's regulated vaping market evolves.
Aug.14
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA’s proposed rule requiring foreign tobacco manufacturers to register establishments and list products is more than routine paperwork, Keller and Heckman LLP partner Azim Chowdhury told 2Firsts. He said it could strengthen FDA’s import enforcement, inspections and market surveillance. Chinese e-cigarette OEM/ODM manufacturers, specification developers, brand owners and component suppliers may need to review their roles, product data and U.S. market authorization status.
Special Report
Jun.29
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05